Roelof Rongen
Fortuna: - $ al 31/08/2026
Fortuna: - $ al 31/08/2026
Roelof Rongen is the founder of Matinas BioPharma, Inc., founded in 2011, serving as President, Chief Executive Officer & Director.
Mr. Rongen was the founder of Innovative Molecules GmbH, founded in 2019, serving as Chief Executive Officer.
Mr. Rongen is also the founder of Essential Fatty Acid Therapeutics LLC..
Mr. Rongen is Chief Executive Officer & Director at Adolore Biotherapeutics, Inc. since 2022.
Mr. Rongen is Independent Director at GRI Bio, Inc. since 2023.
Former positions include Chief Executive Officer & Director at Matinas BioPharma Holdings, Inc. from 2016 to 2018, Executive Director-Marketing at Logistics & Environmental Solutions Corp., Director at Vallon Pharmaceuticals, Inc., Vice President-Life Cycle Management at Reliant Pharmaceuticals LLC from 2000 to 2008, and Executive VP-North American Operations at Trygg Pharma AS from 2009 to 2012.
Education includes undergraduate studies at Wageningen University and an MBA from Kellogg School of Management.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GRI BIO, INC. -.--% | 17/01/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GRI BIO, INC. | Director/Miembro de la Junta | 24/04/2023 |
Matinas BioPharma, Inc. | Fundador | 11/08/2011 |
Essential Fatty Acid Therapeutics LLC | Fundador | - |
Adolore Biotherapeutics, Inc.
Adolore Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing novel therapies for the treatment of chronic, other pain and nervous system | Director Ejecutivo | 01/07/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
| MATINAS BIOPHARMA HOLDINGS, INC. | Director Ejecutivo | 16/03/2018 |
Trygg Pharma AS
Trygg Pharma AS Pharmaceuticals: MajorHealth Technology Develops marine based omega-3 fatty acids for pharmaceutical applications | Corporate Officer/Principal | 01/01/2012 |
Reliant Pharmaceuticals LLC
Reliant Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/2008 |
Innovative Molecules GmbH
Innovative Molecules GmbH Pharmaceuticals: MajorHealth Technology Provides drug development services | Director Ejecutivo | - |
| GRI BIOPAR | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 12 |
|---|---|
Reliant Pharmaceuticals LLC
Reliant Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Matinas BioPharma, Inc. | |
Matinas BioPharma Holdings, Inc.
Matinas BioPharma Holdings, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Logistics & Environmental Solutions Corp.
Logistics & Environmental Solutions Corp. Air Freight/CouriersTransportation Provides logistics solutions for government and commercial markets | Transportation |
Trygg Pharma AS
Trygg Pharma AS Pharmaceuticals: MajorHealth Technology Develops marine based omega-3 fatty acids for pharmaceutical applications | Health Technology |
Wageningen University
Wageningen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Essential Fatty Acid Therapeutics LLC | |
Vallon Pharmaceuticals, Inc.
Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes proprietary biopharmaceutical products | Health Technology |
Innovative Molecules GmbH
Innovative Molecules GmbH Pharmaceuticals: MajorHealth Technology Provides drug development services | Health Technology |
Adolore Biotherapeutics, Inc.
Adolore Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing novel therapies for the treatment of chronic, other pain and nervous system | Health Technology |
GRI Bio, Inc.
GRI Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of inflammatory, fibrotic and autoimmune diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.